fMRI as an outcome measure in clinical trials: A systematic review in clinicaltrials.gov

Alaleh Sadraee, Martin P. Paulus, Hamed Ekhtiari
doi: https://doi.org/10.1101/19002972

Article Information

doi 
https://doi.org/10.1101/19002972
History 
  • July 25, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Alaleh Sadraeea,b,*,
  2. Martin P. Paulusc and
  3. Hamed Ekhtiaric
  1. aInstitute for Cognitive Science Studies, Tehran, Iran
  2. bIranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
  3. cLaureate Institute for Brain Research, Tulsa, OK, United States of America
  1. ↵*Correspondence: Alaleh.sadraee{at}gmail.com
Back to top
Posted July 25, 2019.
Download PDF

Supplementary Material

Data/Code
Email
fMRI as an outcome measure in clinical trials: A systematic review in clinicaltrials.gov
Alaleh Sadraee, Martin P. Paulus, Hamed Ekhtiari
medRxiv 19002972; doi: https://doi.org/10.1101/19002972
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area